nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ADA—pleura—sarcoma	0.0234	0.0705	CbGeAlD
Dipyridamole—PDE8B—larynx—sarcoma	0.0146	0.0438	CbGeAlD
Dipyridamole—PDE8B—leg—sarcoma	0.0127	0.0381	CbGeAlD
Dipyridamole—PDE8B—forelimb—sarcoma	0.0126	0.0378	CbGeAlD
Dipyridamole—PDE5A—pulmonary artery—sarcoma	0.0115	0.0345	CbGeAlD
Dipyridamole—PDE8B—hindlimb—sarcoma	0.0113	0.034	CbGeAlD
Dipyridamole—PDE8B—appendage—sarcoma	0.0097	0.0292	CbGeAlD
Dipyridamole—PDE6B—hematopoietic system—sarcoma	0.00499	0.015	CbGeAlD
Dipyridamole—PDE2A—mammary gland—sarcoma	0.00495	0.0149	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vincristine—sarcoma	0.00494	0.372	CbGdCrCtD
Dipyridamole—PRUNE—Podofilox—Etoposide—sarcoma	0.00493	0.372	CbGdCrCtD
Dipyridamole—PDE6B—connective tissue—sarcoma	0.0048	0.0144	CbGeAlD
Dipyridamole—PDE6A—testis—sarcoma	0.00455	0.0137	CbGeAlD
Dipyridamole—PDE8A—mammary gland—sarcoma	0.00425	0.0128	CbGeAlD
Dipyridamole—PDE7A—hematopoietic system—sarcoma	0.00413	0.0124	CbGeAlD
Dipyridamole—PRUNE—cardiac atrium—sarcoma	0.00399	0.012	CbGeAlD
Dipyridamole—PRUNE—uterus—sarcoma	0.00396	0.0119	CbGeAlD
Dipyridamole—PDE6D—uterus—sarcoma	0.00383	0.0115	CbGeAlD
Dipyridamole—PDE5A—endothelium—sarcoma	0.00359	0.0108	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—sarcoma	0.00351	0.0106	CbGeAlD
Dipyridamole—PDE2A—myometrium—sarcoma	0.00351	0.0106	CbGeAlD
Dipyridamole—PRUNE—tendon—sarcoma	0.00347	0.0104	CbGeAlD
Dipyridamole—PDE4A—mammary gland—sarcoma	0.0034	0.0102	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vincristine—sarcoma	0.00339	0.256	CbGdCrCtD
Dipyridamole—PDE6D—bone marrow—sarcoma	0.00325	0.00977	CbGeAlD
Dipyridamole—PDE1C—testis—sarcoma	0.00319	0.00958	CbGeAlD
Dipyridamole—PDE2A—seminal vesicle—sarcoma	0.00317	0.00953	CbGeAlD
Dipyridamole—PDE11A—tendon—sarcoma	0.00307	0.00922	CbGeAlD
Dipyridamole—PDE8A—myometrium—sarcoma	0.00301	0.00906	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—sarcoma	0.00291	0.00874	CbGeAlD
Dipyridamole—PRUNE—testis—sarcoma	0.00288	0.00865	CbGeAlD
Dipyridamole—PDE3B—hematopoietic system—sarcoma	0.00281	0.00844	CbGeAlD
Dipyridamole—PDE6D—testis—sarcoma	0.00278	0.00835	CbGeAlD
Dipyridamole—PDE6B—testis—sarcoma	0.00273	0.00821	CbGeAlD
Dipyridamole—PDE8A—seminal vesicle—sarcoma	0.00272	0.00818	CbGeAlD
Dipyridamole—PRUNE—liver—sarcoma	0.00272	0.00817	CbGeAlD
Dipyridamole—PDE3B—connective tissue—sarcoma	0.0027	0.00813	CbGeAlD
Dipyridamole—ABCC5—mammary gland—sarcoma	0.00265	0.00796	CbGeAlD
Dipyridamole—PDE6D—liver—sarcoma	0.00263	0.00789	CbGeAlD
Dipyridamole—PDE11A—testis—sarcoma	0.00254	0.00764	CbGeAlD
Dipyridamole—ADA—myometrium—sarcoma	0.00248	0.00745	CbGeAlD
Dipyridamole—PDE6G—testis—sarcoma	0.00245	0.00735	CbGeAlD
Dipyridamole—SLC29A1—mammary gland—sarcoma	0.00243	0.00731	CbGeAlD
Dipyridamole—PDE11A—liver—sarcoma	0.0024	0.00722	CbGeAlD
Dipyridamole—PDE7B—tendon—sarcoma	0.00239	0.00718	CbGeAlD
Dipyridamole—PDE6G—liver—sarcoma	0.00231	0.00695	CbGeAlD
Dipyridamole—PDE1C—lymph node—sarcoma	0.00231	0.00695	CbGeAlD
Dipyridamole—PDE2A—cardiac atrium—sarcoma	0.00229	0.00688	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—sarcoma	0.00228	0.00685	CbGeAlD
Dipyridamole—PDE2A—uterus—sarcoma	0.00228	0.00684	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—sarcoma	0.00221	0.00663	CbGeAlD
Dipyridamole—PDE8B—uterus—sarcoma	0.00217	0.00653	CbGeAlD
Dipyridamole—ADA—hematopoietic system—sarcoma	0.00213	0.0064	CbGeAlD
Dipyridamole—PRUNE—lymph node—sarcoma	0.00208	0.00627	CbGeAlD
Dipyridamole—ADA—connective tissue—sarcoma	0.00205	0.00616	CbGeAlD
Dipyridamole—PDE6D—lymph node—sarcoma	0.00201	0.00605	CbGeAlD
Dipyridamole—PDE2A—tendon—sarcoma	0.002	0.006	CbGeAlD
Dipyridamole—PDE10A—tendon—sarcoma	0.002	0.006	CbGeAlD
Dipyridamole—PDE7B—testis—sarcoma	0.00198	0.00595	CbGeAlD
Dipyridamole—PDE8A—cardiac atrium—sarcoma	0.00196	0.0059	CbGeAlD
Dipyridamole—PDE8A—uterus—sarcoma	0.00195	0.00587	CbGeAlD
Dipyridamole—PDE1A—uterus—sarcoma	0.00189	0.00568	CbGeAlD
Dipyridamole—PDE7B—liver—sarcoma	0.00187	0.00562	CbGeAlD
Dipyridamole—PDE3B—bone marrow—sarcoma	0.0018	0.00541	CbGeAlD
Dipyridamole—PDE6G—lymph node—sarcoma	0.00177	0.00533	CbGeAlD
Dipyridamole—PDE5A—hematopoietic system—sarcoma	0.00176	0.0053	CbGeAlD
Dipyridamole—SLC29A1—myometrium—sarcoma	0.00172	0.00518	CbGeAlD
Dipyridamole—PDE3A—hematopoietic system—sarcoma	0.00172	0.00516	CbGeAlD
Dipyridamole—PDE8A—tendon—sarcoma	0.00171	0.00515	CbGeAlD
Dipyridamole—PDE5A—connective tissue—sarcoma	0.0017	0.0051	CbGeAlD
Dipyridamole—PDE1A—tendon—sarcoma	0.00166	0.00498	CbGeAlD
Dipyridamole—PDE10A—testis—sarcoma	0.00165	0.00497	CbGeAlD
Dipyridamole—PDE2A—testis—sarcoma	0.00165	0.00497	CbGeAlD
Dipyridamole—PDE1B—testis—sarcoma	0.00164	0.00492	CbGeAlD
Dipyridamole—PDE8B—testis—sarcoma	0.00158	0.00474	CbGeAlD
Dipyridamole—PDE2A—liver—sarcoma	0.00156	0.00469	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—sarcoma	0.00155	0.00467	CbGeAlD
Dipyridamole—PDE3B—testis—sarcoma	0.00154	0.00463	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—sarcoma	0.00151	0.00454	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—sarcoma	0.0015	0.0045	CbGeAlD
Dipyridamole—PDE8B—liver—sarcoma	0.00149	0.00448	CbGeAlD
Dipyridamole—SLC29A1—hematopoietic system—sarcoma	0.00148	0.00445	CbGeAlD
Dipyridamole—PDE3B—liver—sarcoma	0.00146	0.00437	CbGeAlD
Dipyridamole—PDE7B—lymph node—sarcoma	0.00143	0.00431	CbGeAlD
Dipyridamole—SLC29A1—connective tissue—sarcoma	0.00143	0.00429	CbGeAlD
Dipyridamole—PDE8A—testis—sarcoma	0.00142	0.00426	CbGeAlD
Dipyridamole—ADA—tendon—sarcoma	0.00141	0.00423	CbGeAlD
Dipyridamole—PDE1A—testis—sarcoma	0.00137	0.00412	CbGeAlD
Dipyridamole—ADA—bone marrow—sarcoma	0.00136	0.0041	CbGeAlD
Dipyridamole—PDE8A—liver—sarcoma	0.00134	0.00403	CbGeAlD
Dipyridamole—PDE3A—cardiac atrium—sarcoma	0.0013	0.00392	CbGeAlD
Dipyridamole—PDE1A—liver—sarcoma	0.0013	0.0039	CbGeAlD
Dipyridamole—ABCC5—cardiac atrium—sarcoma	0.00122	0.00368	CbGeAlD
Dipyridamole—PDE10A—lymph node—sarcoma	0.0012	0.0036	CbGeAlD
Dipyridamole—PDE2A—lymph node—sarcoma	0.0012	0.0036	CbGeAlD
Dipyridamole—PDE1B—lymph node—sarcoma	0.00119	0.00357	CbGeAlD
Dipyridamole—PDE5A—tendon—sarcoma	0.00117	0.00351	CbGeAlD
Dipyridamole—ADA—testis—sarcoma	0.00117	0.00351	CbGeAlD
Dipyridamole—PDE8B—lymph node—sarcoma	0.00114	0.00343	CbGeAlD
Dipyridamole—PDE4A—testis—sarcoma	0.00114	0.00342	CbGeAlD
Dipyridamole—PDE3A—tendon—sarcoma	0.00114	0.00341	CbGeAlD
Dipyridamole—SLC29A1—cardiac atrium—sarcoma	0.00112	0.00338	CbGeAlD
Dipyridamole—SLC29A1—uterus—sarcoma	0.00112	0.00336	CbGeAlD
Dipyridamole—ABCC4—hematopoietic system—sarcoma	0.00112	0.00336	CbGeAlD
Dipyridamole—PDE3B—lymph node—sarcoma	0.00112	0.00335	CbGeAlD
Dipyridamole—ABCC5—tendon—sarcoma	0.00107	0.00321	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—sarcoma	0.00104	0.00313	CbGeAlD
Dipyridamole—ABCC5—bone marrow—sarcoma	0.00103	0.00311	CbGeAlD
Dipyridamole—PDE8A—lymph node—sarcoma	0.00103	0.00309	CbGeAlD
Dipyridamole—PDE1A—lymph node—sarcoma	0.000994	0.00299	CbGeAlD
Dipyridamole—SLC29A1—tendon—sarcoma	0.00098	0.00295	CbGeAlD
Dipyridamole—PDE5A—testis—sarcoma	0.000967	0.00291	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—sarcoma	0.00095	0.00285	CbGeAlD
Dipyridamole—PDE3A—testis—sarcoma	0.00094	0.00283	CbGeAlD
Dipyridamole—PDE3A—liver—sarcoma	0.000889	0.00267	CbGeAlD
Dipyridamole—ABCC5—testis—sarcoma	0.000884	0.00266	CbGeAlD
Dipyridamole—ADA—lymph node—sarcoma	0.000846	0.00254	CbGeAlD
Dipyridamole—ABCC4—uterus—sarcoma	0.000845	0.00254	CbGeAlD
Dipyridamole—ABCC5—liver—sarcoma	0.000836	0.00251	CbGeAlD
Dipyridamole—PDE4A—lymph node—sarcoma	0.000824	0.00248	CbGeAlD
Dipyridamole—SLC29A1—testis—sarcoma	0.000812	0.00244	CbGeAlD
Dipyridamole—SLC29A1—liver—sarcoma	0.000767	0.00231	CbGeAlD
Dipyridamole—ABCC4—tendon—sarcoma	0.00074	0.00222	CbGeAlD
Dipyridamole—ABCC4—bone marrow—sarcoma	0.000717	0.00215	CbGeAlD
Dipyridamole—PDE5A—lymph node—sarcoma	0.000701	0.00211	CbGeAlD
Dipyridamole—PDE3A—lymph node—sarcoma	0.000682	0.00205	CbGeAlD
Dipyridamole—ABCC5—lymph node—sarcoma	0.000641	0.00193	CbGeAlD
Dipyridamole—ABCC4—testis—sarcoma	0.000613	0.00184	CbGeAlD
Dipyridamole—Anaemia—Etoposide—sarcoma	0.000588	0.0021	CcSEcCtD
Dipyridamole—SLC29A1—lymph node—sarcoma	0.000588	0.00177	CbGeAlD
Dipyridamole—Gastrointestinal pain—Dactinomycin—sarcoma	0.000587	0.0021	CcSEcCtD
Dipyridamole—Hot flush—Doxorubicin—sarcoma	0.000586	0.00209	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Vincristine—sarcoma	0.000584	0.00209	CcSEcCtD
Dipyridamole—Hypotension—Mitoxantrone—sarcoma	0.000584	0.00208	CcSEcCtD
Dipyridamole—Increased appetite—Doxorubicin—sarcoma	0.000584	0.00208	CcSEcCtD
Dipyridamole—Migraine—Epirubicin—sarcoma	0.000583	0.00208	CcSEcCtD
Dipyridamole—Menopausal symptoms—Doxorubicin—sarcoma	0.000581	0.00207	CcSEcCtD
Dipyridamole—ABCC4—liver—sarcoma	0.000579	0.00174	CbGeAlD
Dipyridamole—Paraesthesia—Vincristine—sarcoma	0.000576	0.00206	CcSEcCtD
Dipyridamole—Urticaria—Thiotepa—sarcoma	0.000575	0.00205	CcSEcCtD
Dipyridamole—Malaise—Etoposide—sarcoma	0.000574	0.00205	CcSEcCtD
Dipyridamole—Vertigo—Etoposide—sarcoma	0.000572	0.00204	CcSEcCtD
Dipyridamole—Abdominal pain—Thiotepa—sarcoma	0.000572	0.00204	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000569	0.00203	CcSEcCtD
Dipyridamole—Abdominal pain—Dactinomycin—sarcoma	0.000568	0.00203	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000567	0.00202	CcSEcCtD
Dipyridamole—Cardiac arrest—Epirubicin—sarcoma	0.000563	0.00201	CcSEcCtD
Dipyridamole—Paraesthesia—Mitoxantrone—sarcoma	0.000561	0.002	CcSEcCtD
Dipyridamole—Loss of consciousness—Etoposide—sarcoma	0.00056	0.002	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Doxorubicin—sarcoma	0.00056	0.002	CcSEcCtD
Dipyridamole—Dyspnoea—Mitoxantrone—sarcoma	0.000557	0.00199	CcSEcCtD
Dipyridamole—Cough—Etoposide—sarcoma	0.000556	0.00198	CcSEcCtD
Dipyridamole—Somnolence—Mitoxantrone—sarcoma	0.000555	0.00198	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Vincristine—sarcoma	0.000554	0.00198	CcSEcCtD
Dipyridamole—Fatigue—Vincristine—sarcoma	0.000553	0.00197	CcSEcCtD
Dipyridamole—Convulsion—Etoposide—sarcoma	0.000552	0.00197	CcSEcCtD
Dipyridamole—Dyspepsia—Mitoxantrone—sarcoma	0.00055	0.00196	CcSEcCtD
Dipyridamole—Hypertension—Etoposide—sarcoma	0.00055	0.00196	CcSEcCtD
Dipyridamole—Pain—Vincristine—sarcoma	0.000548	0.00196	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000548	0.00196	CcSEcCtD
Dipyridamole—Chest pain—Etoposide—sarcoma	0.000542	0.00193	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Epirubicin—sarcoma	0.000541	0.00193	CcSEcCtD
Dipyridamole—Abdominal pain upper—Epirubicin—sarcoma	0.000541	0.00193	CcSEcCtD
Dipyridamole—Migraine—Doxorubicin—sarcoma	0.00054	0.00193	CcSEcCtD
Dipyridamole—Fatigue—Mitoxantrone—sarcoma	0.000539	0.00192	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000538	0.00192	CcSEcCtD
Dipyridamole—Discomfort—Etoposide—sarcoma	0.000536	0.00191	CcSEcCtD
Dipyridamole—Pain—Mitoxantrone—sarcoma	0.000534	0.00191	CcSEcCtD
Dipyridamole—Hypersensitivity—Thiotepa—sarcoma	0.000533	0.0019	CcSEcCtD
Dipyridamole—Hypersensitivity—Dactinomycin—sarcoma	0.000529	0.00189	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Vincristine—sarcoma	0.000524	0.00187	CcSEcCtD
Dipyridamole—Cardiac arrest—Doxorubicin—sarcoma	0.000521	0.00186	CcSEcCtD
Dipyridamole—Anaphylactic shock—Etoposide—sarcoma	0.00052	0.00185	CcSEcCtD
Dipyridamole—Asthenia—Thiotepa—sarcoma	0.000519	0.00185	CcSEcCtD
Dipyridamole—Asthenia—Dactinomycin—sarcoma	0.000515	0.00184	CcSEcCtD
Dipyridamole—Feeling abnormal—Mitoxantrone—sarcoma	0.000515	0.00184	CcSEcCtD
Dipyridamole—Dysphagia—Epirubicin—sarcoma	0.000512	0.00183	CcSEcCtD
Dipyridamole—Pruritus—Thiotepa—sarcoma	0.000512	0.00183	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000511	0.00182	CcSEcCtD
Dipyridamole—Thrombocytopenia—Etoposide—sarcoma	0.000509	0.00182	CcSEcCtD
Dipyridamole—Tachycardia—Etoposide—sarcoma	0.000507	0.00181	CcSEcCtD
Dipyridamole—Abdominal pain—Vincristine—sarcoma	0.000507	0.00181	CcSEcCtD
Dipyridamole—Skin disorder—Etoposide—sarcoma	0.000505	0.0018	CcSEcCtD
Dipyridamole—Hyperhidrosis—Etoposide—sarcoma	0.000502	0.00179	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—sarcoma	0.000501	0.00179	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—sarcoma	0.000501	0.00179	CcSEcCtD
Dipyridamole—Angina pectoris—Epirubicin—sarcoma	0.000499	0.00178	CcSEcCtD
Dipyridamole—Urticaria—Mitoxantrone—sarcoma	0.000496	0.00177	CcSEcCtD
Dipyridamole—Diarrhoea—Thiotepa—sarcoma	0.000495	0.00177	CcSEcCtD
Dipyridamole—Abdominal pain—Mitoxantrone—sarcoma	0.000494	0.00176	CcSEcCtD
Dipyridamole—Diarrhoea—Dactinomycin—sarcoma	0.000491	0.00175	CcSEcCtD
Dipyridamole—Hypotension—Etoposide—sarcoma	0.000486	0.00173	CcSEcCtD
Dipyridamole—Dizziness—Thiotepa—sarcoma	0.000478	0.00171	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—sarcoma	0.000474	0.00169	CcSEcCtD
Dipyridamole—Hypersensitivity—Vincristine—sarcoma	0.000473	0.00169	CcSEcCtD
Dipyridamole—Paraesthesia—Etoposide—sarcoma	0.000467	0.00167	CcSEcCtD
Dipyridamole—Dyspnoea—Etoposide—sarcoma	0.000463	0.00165	CcSEcCtD
Dipyridamole—Somnolence—Etoposide—sarcoma	0.000462	0.00165	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—sarcoma	0.000462	0.00165	CcSEcCtD
Dipyridamole—Hypersensitivity—Mitoxantrone—sarcoma	0.00046	0.00164	CcSEcCtD
Dipyridamole—Asthenia—Vincristine—sarcoma	0.00046	0.00164	CcSEcCtD
Dipyridamole—Vomiting—Thiotepa—sarcoma	0.00046	0.00164	CcSEcCtD
Dipyridamole—Vomiting—Dactinomycin—sarcoma	0.000456	0.00163	CcSEcCtD
Dipyridamole—Rash—Thiotepa—sarcoma	0.000456	0.00163	CcSEcCtD
Dipyridamole—Dermatitis—Thiotepa—sarcoma	0.000456	0.00163	CcSEcCtD
Dipyridamole—ABCB1—myometrium—sarcoma	0.000453	0.00136	CbGeAlD
Dipyridamole—Headache—Thiotepa—sarcoma	0.000453	0.00162	CcSEcCtD
Dipyridamole—Rash—Dactinomycin—sarcoma	0.000453	0.00162	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Etoposide—sarcoma	0.000449	0.0016	CcSEcCtD
Dipyridamole—Asthenia—Mitoxantrone—sarcoma	0.000448	0.0016	CcSEcCtD
Dipyridamole—Fatigue—Etoposide—sarcoma	0.000448	0.0016	CcSEcCtD
Dipyridamole—Pain—Etoposide—sarcoma	0.000444	0.00159	CcSEcCtD
Dipyridamole—ABCC4—lymph node—sarcoma	0.000444	0.00134	CbGeAlD
Dipyridamole—Diarrhoea—Vincristine—sarcoma	0.000439	0.00157	CcSEcCtD
Dipyridamole—ABCB1—embryo—sarcoma	0.000436	0.00131	CbGeAlD
Dipyridamole—Nausea—Thiotepa—sarcoma	0.00043	0.00153	CcSEcCtD
Dipyridamole—Feeling abnormal—Etoposide—sarcoma	0.000428	0.00153	CcSEcCtD
Dipyridamole—Diarrhoea—Mitoxantrone—sarcoma	0.000427	0.00153	CcSEcCtD
Dipyridamole—Nausea—Dactinomycin—sarcoma	0.000426	0.00152	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Etoposide—sarcoma	0.000425	0.00152	CcSEcCtD
Dipyridamole—Dizziness—Vincristine—sarcoma	0.000424	0.00151	CcSEcCtD
Dipyridamole—Bradycardia—Epirubicin—sarcoma	0.000417	0.00149	CcSEcCtD
Dipyridamole—Urticaria—Etoposide—sarcoma	0.000413	0.00147	CcSEcCtD
Dipyridamole—Haemoglobin—Epirubicin—sarcoma	0.000412	0.00147	CcSEcCtD
Dipyridamole—Rhinitis—Epirubicin—sarcoma	0.000411	0.00147	CcSEcCtD
Dipyridamole—Abdominal pain—Etoposide—sarcoma	0.000411	0.00147	CcSEcCtD
Dipyridamole—Haemorrhage—Epirubicin—sarcoma	0.00041	0.00146	CcSEcCtD
Dipyridamole—Hepatitis—Epirubicin—sarcoma	0.00041	0.00146	CcSEcCtD
Dipyridamole—ABCB1—seminal vesicle—sarcoma	0.00041	0.00123	CbGeAlD
Dipyridamole—Hypoaesthesia—Epirubicin—sarcoma	0.000408	0.00146	CcSEcCtD
Dipyridamole—Vomiting—Vincristine—sarcoma	0.000408	0.00146	CcSEcCtD
Dipyridamole—Pharyngitis—Epirubicin—sarcoma	0.000407	0.00145	CcSEcCtD
Dipyridamole—Rash—Vincristine—sarcoma	0.000404	0.00144	CcSEcCtD
Dipyridamole—Dermatitis—Vincristine—sarcoma	0.000404	0.00144	CcSEcCtD
Dipyridamole—Headache—Vincristine—sarcoma	0.000402	0.00143	CcSEcCtD
Dipyridamole—Vomiting—Mitoxantrone—sarcoma	0.000397	0.00142	CcSEcCtD
Dipyridamole—Rash—Mitoxantrone—sarcoma	0.000394	0.00141	CcSEcCtD
Dipyridamole—Dermatitis—Mitoxantrone—sarcoma	0.000393	0.0014	CcSEcCtD
Dipyridamole—Headache—Mitoxantrone—sarcoma	0.000391	0.0014	CcSEcCtD
Dipyridamole—ABCB1—hematopoietic system—sarcoma	0.000389	0.00117	CbGeAlD
Dipyridamole—Bradycardia—Doxorubicin—sarcoma	0.000386	0.00138	CcSEcCtD
Dipyridamole—Hypersensitivity—Etoposide—sarcoma	0.000383	0.00137	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—sarcoma	0.000382	0.00136	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—sarcoma	0.000381	0.00136	CcSEcCtD
Dipyridamole—Nausea—Vincristine—sarcoma	0.000381	0.00136	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—sarcoma	0.00038	0.00136	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—sarcoma	0.00038	0.00136	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—sarcoma	0.00038	0.00136	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—sarcoma	0.000379	0.00135	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—sarcoma	0.000379	0.00135	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—sarcoma	0.000377	0.00135	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—sarcoma	0.000376	0.00134	CcSEcCtD
Dipyridamole—Asthenia—Etoposide—sarcoma	0.000373	0.00133	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—sarcoma	0.000372	0.00133	CcSEcCtD
Dipyridamole—Nausea—Mitoxantrone—sarcoma	0.000371	0.00132	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—sarcoma	0.00037	0.00132	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—sarcoma	0.000369	0.00132	CcSEcCtD
Dipyridamole—Chills—Epirubicin—sarcoma	0.000368	0.00131	CcSEcCtD
Dipyridamole—Pruritus—Etoposide—sarcoma	0.000368	0.00131	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—sarcoma	0.000366	0.00131	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—sarcoma	0.000362	0.00129	CcSEcCtD
Dipyridamole—Diarrhoea—Etoposide—sarcoma	0.000356	0.00127	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—sarcoma	0.000354	0.00126	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—sarcoma	0.000352	0.00126	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—sarcoma	0.000352	0.00126	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—sarcoma	0.000352	0.00126	CcSEcCtD
Dipyridamole—Tension—Epirubicin—sarcoma	0.00035	0.00125	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—sarcoma	0.000349	0.00125	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—sarcoma	0.000347	0.00124	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—sarcoma	0.000345	0.00123	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—sarcoma	0.000344	0.00123	CcSEcCtD
Dipyridamole—Dizziness—Etoposide—sarcoma	0.000344	0.00123	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—sarcoma	0.000343	0.00122	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—sarcoma	0.000343	0.00122	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—sarcoma	0.000342	0.00122	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—sarcoma	0.00034	0.00122	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—sarcoma	0.000339	0.00121	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—sarcoma	0.000335	0.0012	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—sarcoma	0.000331	0.00118	CcSEcCtD
Dipyridamole—Vomiting—Etoposide—sarcoma	0.00033	0.00118	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—sarcoma	0.00033	0.00118	CcSEcCtD
Dipyridamole—Rash—Etoposide—sarcoma	0.000328	0.00117	CcSEcCtD
Dipyridamole—Dermatitis—Etoposide—sarcoma	0.000327	0.00117	CcSEcCtD
Dipyridamole—Headache—Etoposide—sarcoma	0.000326	0.00116	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—sarcoma	0.000325	0.00116	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—sarcoma	0.000324	0.00116	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—sarcoma	0.000323	0.00115	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—sarcoma	0.000322	0.00115	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—sarcoma	0.000321	0.00114	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—sarcoma	0.000321	0.00114	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—sarcoma	0.00032	0.00114	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—sarcoma	0.000319	0.00114	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—sarcoma	0.000317	0.00113	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—sarcoma	0.000315	0.00113	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—sarcoma	0.000314	0.00112	CcSEcCtD
Dipyridamole—Cough—Epirubicin—sarcoma	0.000311	0.00111	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—sarcoma	0.000309	0.0011	CcSEcCtD
Dipyridamole—Nausea—Etoposide—sarcoma	0.000309	0.0011	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—sarcoma	0.000308	0.0011	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—sarcoma	0.000306	0.00109	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—sarcoma	0.000305	0.00109	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—sarcoma	0.000304	0.00108	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—sarcoma	0.000304	0.00108	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—sarcoma	0.000304	0.00108	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—sarcoma	0.000303	0.00108	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000302	0.00108	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—sarcoma	0.0003	0.00107	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—sarcoma	0.000298	0.00106	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—sarcoma	0.000297	0.00106	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—sarcoma	0.000297	0.00106	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—sarcoma	0.000296	0.00106	CcSEcCtD
Dipyridamole—ABCB1—uterus—sarcoma	0.000294	0.000884	CbGeAlD
Dipyridamole—Palpitations—Doxorubicin—sarcoma	0.000292	0.00104	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—sarcoma	0.000291	0.00104	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—sarcoma	0.000291	0.00104	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—sarcoma	0.00029	0.00104	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—sarcoma	0.000288	0.00103	CcSEcCtD
Dipyridamole—Shock—Epirubicin—sarcoma	0.000287	0.00102	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—sarcoma	0.000286	0.00102	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—sarcoma	0.000286	0.00102	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—sarcoma	0.000285	0.00102	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—sarcoma	0.000285	0.00102	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—sarcoma	0.000284	0.00101	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—sarcoma	0.000283	0.00101	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—sarcoma	0.000282	0.00101	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—sarcoma	0.000281	0.001	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—sarcoma	0.000281	0.001	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—sarcoma	0.000281	0.001	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—sarcoma	0.00028	0.001	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000279	0.000997	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—sarcoma	0.000278	0.000992	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—sarcoma	0.000275	0.000981	CcSEcCtD
Dipyridamole—ABCB1—lymphoid tissue—sarcoma	0.000274	0.000824	CbGeAlD
Dipyridamole—Hypotension—Epirubicin—sarcoma	0.000272	0.000972	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—sarcoma	0.000269	0.000962	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—sarcoma	0.000269	0.000962	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000265	0.000947	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—sarcoma	0.000265	0.000946	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—sarcoma	0.000264	0.000943	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—sarcoma	0.000264	0.000942	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—sarcoma	0.000263	0.000939	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—sarcoma	0.000262	0.000934	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—sarcoma	0.000262	0.000934	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—sarcoma	0.000261	0.00093	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—sarcoma	0.00026	0.000927	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—sarcoma	0.000259	0.000924	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—sarcoma	0.000256	0.000915	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—sarcoma	0.000252	0.000899	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—sarcoma	0.000251	0.000898	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—sarcoma	0.000251	0.000896	CcSEcCtD
Dipyridamole—ABCB1—bone marrow—sarcoma	0.00025	0.00075	CbGeAlD
Dipyridamole—Pain—Epirubicin—sarcoma	0.000249	0.000889	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000246	0.000876	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—sarcoma	0.000242	0.000864	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—sarcoma	0.00024	0.000858	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—sarcoma	0.00024	0.000857	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—sarcoma	0.00024	0.000855	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—sarcoma	0.000238	0.00085	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—sarcoma	0.000237	0.000847	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000233	0.000831	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—sarcoma	0.000232	0.000829	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—sarcoma	0.000231	0.000826	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—sarcoma	0.00023	0.000823	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—sarcoma	0.00023	0.000822	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—sarcoma	0.000222	0.000793	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—sarcoma	0.00022	0.000787	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—sarcoma	0.000215	0.000766	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—sarcoma	0.000214	0.000764	CcSEcCtD
Dipyridamole—ABCB1—testis—sarcoma	0.000213	0.000641	CbGeAlD
Dipyridamole—Abdominal pain—Doxorubicin—sarcoma	0.000213	0.000761	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—sarcoma	0.000209	0.000746	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—sarcoma	0.000206	0.000736	CcSEcCtD
Dipyridamole—ABCB1—liver—sarcoma	0.000202	0.000606	CbGeAlD
Dipyridamole—Diarrhoea—Epirubicin—sarcoma	0.000199	0.000711	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—sarcoma	0.000199	0.000709	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—sarcoma	0.000193	0.00069	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—sarcoma	0.000193	0.000688	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—sarcoma	0.000191	0.000681	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—sarcoma	0.000185	0.000661	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—sarcoma	0.000184	0.000658	CcSEcCtD
Dipyridamole—Rash—Epirubicin—sarcoma	0.000184	0.000656	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—sarcoma	0.000183	0.000655	CcSEcCtD
Dipyridamole—Headache—Epirubicin—sarcoma	0.000182	0.000651	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—sarcoma	0.000178	0.000636	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—sarcoma	0.000173	0.000618	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—sarcoma	0.000171	0.000612	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—sarcoma	0.00017	0.000607	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—sarcoma	0.00017	0.000606	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—sarcoma	0.000169	0.000603	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—sarcoma	0.00016	0.000571	CcSEcCtD
Dipyridamole—ABCB1—lymph node—sarcoma	0.000155	0.000465	CbGeAlD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—sarcoma	5.18e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—sarcoma	5.17e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—sarcoma	5.17e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PDGFRA—sarcoma	5.13e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CCND1—sarcoma	5.12e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NRAS—sarcoma	5.12e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—JUN—sarcoma	5.11e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—sarcoma	5.1e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CTNNB1—sarcoma	5.07e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—HRAS—sarcoma	5.07e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CCND1—sarcoma	5.05e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—sarcoma	5.05e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—JUN—sarcoma	5.04e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KDR—sarcoma	5.04e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—sarcoma	5.04e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1R—sarcoma	5.02e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CTNNB1—sarcoma	5e-05	0.000134	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—SRC—sarcoma	4.99e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HRAS—sarcoma	4.99e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—SRC—sarcoma	4.95e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—SRC—sarcoma	4.95e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CREB1—sarcoma	4.95e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—KRAS—sarcoma	4.94e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—KRAS—sarcoma	4.94e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—HRAS—sarcoma	4.94e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—HRAS—sarcoma	4.94e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CCND1—sarcoma	4.92e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—JUN—sarcoma	4.91e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—KRAS—sarcoma	4.91e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CTNNB1—sarcoma	4.88e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—sarcoma	4.86e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—sarcoma	4.85e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MDM2—sarcoma	4.85e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	4.82e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—sarcoma	4.82e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—sarcoma	4.82e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—KRAS—sarcoma	4.82e-05	0.000129	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	4.81e-05	0.000129	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—NRAS—sarcoma	4.8e-05	0.000128	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	4.78e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FOXO1—sarcoma	4.77e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—sarcoma	4.77e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MYC—sarcoma	4.77e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PDGFRB—sarcoma	4.77e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NRAS—sarcoma	4.76e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NRAS—sarcoma	4.76e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—sarcoma	4.74e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KDR—sarcoma	4.72e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PDGFRA—sarcoma	4.69e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—sarcoma	4.66e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KIT—sarcoma	4.65e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—NRAS—sarcoma	4.65e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—HRAS—sarcoma	4.64e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HRAS—sarcoma	4.61e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KDR—sarcoma	4.59e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—SRC—sarcoma	4.58e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HRAS—sarcoma	4.57e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HRAS—sarcoma	4.55e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—SRC—sarcoma	4.52e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MDM2—sarcoma	4.47e-05	0.00012	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MDM2—sarcoma	4.47e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—sarcoma	4.47e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MYC—sarcoma	4.43e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MYC—sarcoma	4.43e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MDM2—sarcoma	4.43e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CREB1—sarcoma	4.42e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NRAS—sarcoma	4.41e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—SRC—sarcoma	4.41e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—sarcoma	4.41e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KRAS—sarcoma	4.4e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—sarcoma	4.39e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—sarcoma	4.39e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NRAS—sarcoma	4.35e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KIT—sarcoma	4.35e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—NRAS—sarcoma	4.35e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—sarcoma	4.33e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—sarcoma	4.33e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—sarcoma	4.33e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—sarcoma	4.33e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KDR—sarcoma	4.32e-05	0.000115	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	4.32e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—sarcoma	4.29e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—sarcoma	4.28e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NRAS—sarcoma	4.24e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—sarcoma	4.23e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KIT—sarcoma	4.23e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—NRAS—sarcoma	4.23e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—JUN—sarcoma	4.21e-05	0.000113	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.2e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HRAS—sarcoma	4.2e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HRAS—sarcoma	4.2e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CTNNB1—sarcoma	4.18e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HRAS—sarcoma	4.18e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CREB1—sarcoma	4.14e-05	0.000111	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—KRAS—sarcoma	4.14e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MYC—sarcoma	4.11e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KRAS—sarcoma	4.09e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KRAS—sarcoma	4.09e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—sarcoma	4.09e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MDM2—sarcoma	4.09e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MYC—sarcoma	4.05e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CREB1—sarcoma	4.03e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—sarcoma	4.02e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—KRAS—sarcoma	4e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KIT—sarcoma	3.98e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—NRAS—sarcoma	3.98e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—sarcoma	3.96e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—sarcoma	3.96e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—sarcoma	3.96e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—sarcoma	3.95e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KDR—sarcoma	3.95e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—sarcoma	3.91e-05	0.000105	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.87e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—sarcoma	3.86e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CTNNB1—sarcoma	3.86e-05	0.000103	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CTNNB1—sarcoma	3.86e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—sarcoma	3.85e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—JUN—sarcoma	3.85e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTNNB1—sarcoma	3.82e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—sarcoma	3.8e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CREB1—sarcoma	3.79e-05	0.000101	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.78e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SRC—sarcoma	3.78e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—sarcoma	3.75e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—sarcoma	3.74e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—sarcoma	3.74e-05	0.0001	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—sarcoma	3.68e-05	9.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MDM2—sarcoma	3.66e-05	9.78e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—sarcoma	3.65e-05	9.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—sarcoma	3.64e-05	9.74e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—sarcoma	3.64e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—sarcoma	3.64e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KIT—sarcoma	3.64e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—NRAS—sarcoma	3.64e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NRAS—sarcoma	3.63e-05	9.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—sarcoma	3.62e-05	9.69e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	3.57e-05	9.56e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CTNNB1—sarcoma	3.53e-05	9.44e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—sarcoma	3.51e-05	9.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SRC—sarcoma	3.49e-05	9.33e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SRC—sarcoma	3.49e-05	9.33e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—sarcoma	3.48e-05	9.31e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—sarcoma	3.48e-05	9.31e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CREB1—sarcoma	3.46e-05	9.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SRC—sarcoma	3.46e-05	9.24e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MDM2—sarcoma	3.43e-05	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—sarcoma	3.42e-05	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—sarcoma	3.4e-05	9.09e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—sarcoma	3.37e-05	9.02e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NRAS—sarcoma	3.36e-05	8.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NRAS—sarcoma	3.36e-05	8.97e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MDM2—sarcoma	3.33e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—sarcoma	3.33e-05	8.9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NRAS—sarcoma	3.32e-05	8.89e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—sarcoma	3.31e-05	8.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—sarcoma	3.31e-05	8.86e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—sarcoma	3.27e-05	8.74e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—sarcoma	3.24e-05	8.68e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—sarcoma	3.23e-05	8.63e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SRC—sarcoma	3.19e-05	8.53e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCND1—sarcoma	3.19e-05	8.52e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—sarcoma	3.18e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—sarcoma	3.18e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—sarcoma	3.18e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.18e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—sarcoma	3.16e-05	8.44e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—sarcoma	3.13e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—sarcoma	3.13e-05	8.37e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—sarcoma	3.13e-05	8.37e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—sarcoma	3.13e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—sarcoma	3.13e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—sarcoma	3.1e-05	8.3e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—sarcoma	3.1e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—sarcoma	3.07e-05	8.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—sarcoma	3.06e-05	8.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—sarcoma	3.06e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—sarcoma	3.06e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—sarcoma	3.03e-05	8.1e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—sarcoma	2.98e-05	7.98e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—sarcoma	2.98e-05	7.96e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—sarcoma	2.98e-05	7.96e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—sarcoma	2.95e-05	7.9e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—sarcoma	2.91e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—sarcoma	2.9e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—sarcoma	2.9e-05	7.75e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—sarcoma	2.89e-05	7.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—sarcoma	2.89e-05	7.72e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—sarcoma	2.87e-05	7.69e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—sarcoma	2.87e-05	7.66e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—sarcoma	2.86e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—sarcoma	2.86e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—sarcoma	2.85e-05	7.63e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO2—sarcoma	2.85e-05	7.62e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA1—sarcoma	2.83e-05	7.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—sarcoma	2.8e-05	7.49e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—sarcoma	2.8e-05	7.48e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—sarcoma	2.78e-05	7.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—sarcoma	2.74e-05	7.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—sarcoma	2.73e-05	7.3e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—sarcoma	2.72e-05	7.28e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—sarcoma	2.7e-05	7.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—sarcoma	2.67e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—sarcoma	2.66e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—sarcoma	2.66e-05	7.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—sarcoma	2.64e-05	7.06e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—sarcoma	2.6e-05	6.96e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—sarcoma	2.6e-05	6.95e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—sarcoma	2.57e-05	6.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—sarcoma	2.56e-05	6.85e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—sarcoma	2.56e-05	6.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—sarcoma	2.53e-05	6.77e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—sarcoma	2.5e-05	6.69e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—sarcoma	2.5e-05	6.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—sarcoma	2.5e-05	6.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—sarcoma	2.49e-05	6.66e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—sarcoma	2.47e-05	6.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—sarcoma	2.45e-05	6.57e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—sarcoma	2.45e-05	6.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—sarcoma	2.44e-05	6.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—sarcoma	2.43e-05	6.5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLCG1—sarcoma	2.42e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—sarcoma	2.39e-05	6.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—sarcoma	2.38e-05	6.36e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—sarcoma	2.36e-05	6.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—sarcoma	2.35e-05	6.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—sarcoma	2.34e-05	6.26e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—sarcoma	2.33e-05	6.23e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—sarcoma	2.28e-05	6.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—sarcoma	2.25e-05	6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—sarcoma	2.23e-05	5.97e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—sarcoma	2.21e-05	5.91e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—sarcoma	2.19e-05	5.85e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—sarcoma	2.18e-05	5.82e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—sarcoma	2.15e-05	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—sarcoma	2.15e-05	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—sarcoma	2.14e-05	5.73e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—sarcoma	2.1e-05	5.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—sarcoma	2.02e-05	5.41e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—sarcoma	2.01e-05	5.37e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—sarcoma	2e-05	5.35e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—sarcoma	1.97e-05	5.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—sarcoma	1.96e-05	5.24e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—sarcoma	1.91e-05	5.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—sarcoma	1.88e-05	5.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—sarcoma	1.85e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—sarcoma	1.83e-05	4.89e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—sarcoma	1.8e-05	4.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—sarcoma	1.72e-05	4.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—sarcoma	1.64e-05	4.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—sarcoma	1.57e-05	4.2e-05	CbGpPWpGaD
